Determination of oxamniquine in capsules by HPLC

dc.contributor.authorPierri, E. G.
dc.contributor.authorAlmeida, Adelia Emilia de [UNESP]
dc.contributor.authorGremiao, MPD
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:24:32Z
dc.date.available2014-05-20T13:24:32Z
dc.date.issued2001-11-01
dc.description.abstractA sensitive, accurate, reliable and easy method was developed for the quantification of oxamniquine in capsules using high-performance liquid chromatography (HPLC) with UV detection. This technique provided conditions for the separation of the active ingredient from the dosage form by extraction in methanol. Isocratic reversed phase chromatography was performed using methanol, water, and triethanolamine (60:40:0.099, v/v/w) (System C) or methanol, acetonitrile, water and formic acid (40:30:30:0.083, v/v/w) (System D) as mobile phase, a stainless steel column (125 x 4 mm i.d., 5 mum) filled with LiChrospher 100 RP-18 (Merck), column temperature of 28 +/- 2 degreesC and detection at 260 nm. The calibration curves were linear over a wide concentration range (1.0-20.0 mug ml(-1) of oxamniquine) to the Systems C and D with good correlation factor (0.9990 and 0.9982, respectively). The average content obtained were 100.1 +/- 1.5% (System C) and 102.4 +/- 0.8% (System D). The presence of lactose, starch, magnesium stearate and sodium laurylsulphate did not interfere in the results of the analysis. The above findings showed the proposed method to be both simple and added advantage of allowing for fast analysis. (C) 2001 Elsevier B.V. B.V. All rights reserved.en
dc.description.affiliationUNESP, Fac Ciências Farmaceut, BR-14802902 Araraquara, SP, Brazil
dc.description.affiliationUNESP, Program Posgrad Ciências Farmaceut, BR-14802902 Araraquara, SP, Brazil
dc.description.affiliationUnespUNESP, Fac Ciências Farmaceut, BR-14802902 Araraquara, SP, Brazil
dc.description.affiliationUnespUNESP, Program Posgrad Ciências Farmaceut, BR-14802902 Araraquara, SP, Brazil
dc.format.extent675-679
dc.identifierhttp://dx.doi.org/10.1016/S0731-7085(01)00453-8
dc.identifier.citationJournal of Pharmaceutical and Biomedical Analysis. Oxford: Pergamon-Elsevier B.V., v. 26, n. 4, p. 675-679, 2001.
dc.identifier.doi10.1016/S0731-7085(01)00453-8
dc.identifier.issn0731-7085
dc.identifier.urihttp://hdl.handle.net/11449/7639
dc.identifier.wosWOS:000171735500019
dc.language.isoeng
dc.publisherElsevier B.V.
dc.relation.ispartofJournal of Pharmaceutical and Biomedical Analysis
dc.relation.ispartofjcr2.831
dc.relation.ispartofsjr0,919
dc.rights.accessRightsAcesso restrito
dc.sourceWeb of Science
dc.subjectoxamniquinept
dc.subjecthigh-performance liquid chromatography (HPLC)pt
dc.subjectcapsulespt
dc.titleDetermination of oxamniquine in capsules by HPLCen
dc.typeArtigo
dcterms.licensehttp://www.elsevier.com/about/open-access/open-access-policies/article-posting-policy
dcterms.rightsHolderElsevier B.V.
unesp.campusUniversidade Estadual Paulista (Unesp), Faculdade de Ciências Farmacêuticas, Araraquarapt
unesp.departmentFármacos e Medicamentos - FCFpt

Arquivos

Licença do Pacote

Agora exibindo 1 - 1 de 1
Nenhuma Miniatura disponível
Nome:
license.txt
Tamanho:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descrição: